logo

For the Inventor, By the Inventor

Minnetonka, MN, United States of America

Respicardia, Inc.


USPTO Granted Patents = 18


Trademarks = 6

Forward Citations = 620

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Mark Gelfand (12 out of 216 patents)

silverMedal Randy W Westlund (11 out of 100 patents)

bronzeMedal Mark C Lynn (6 out of 15 patents)

4.  Howard R Levin (6 out of 131 patents)

5.  Antonis Panteleon (4 out of 6 patents)

6.  Kristofer J James (4 out of 39 patents)

7.  Andrew Victor Halpert (4 out of 41 patents)

8.  Todd P Goblish (2 out of 15 patents)

9.  Howard Levin (1 out of 52 patents)


18 patents:

1. 10821280 - Medical lead and implantation (2020-11-03),
2. 10603491 - Detecting and treating disordered breathing (2020-03-31),
3. 10543363 - Transvascular medical lead (2020-01-28),
4. 10518090 - System and method to modulate phrenic nerve to prevent sleep apnea (2019-12-31),
5. 10507322 - Medical lead with performed bias (2019-12-17),
6. 10406366 - Transvenous phrenic nerve stimulation system (2019-09-10),
7. 10300270 - Device and method for the treatment of breathing disorders and cardiac disorders (2019-05-28),
8. 9999768 - Respiratory rectification (2018-06-19),
9. 9987488 - Detecting and treating disordered breathing (2018-06-05),
10. 9744351 - Device and method for the treatment of breathing disorders and cardiac disorders (2017-08-29),
11. 9744349 - Medical lead and implantation (2017-08-29),
12. 9468755 - Medical lead with preformed bias (2016-10-18),
13. 9295846 - Muscle and nerve stimulation (2016-03-29),
14. 9199075 - Transvascular medical lead (2015-12-01),
15. 8909341 - Device and method for the treatment of breathing disorders and cardiac disorders (2014-12-09),
Company Overview
Respicardia, Inc. is a medical technology company based in Minnetonka, Minnesota, specializing in innovative solutions for the treatment of sleep-disordered breathing, particularly central sleep apnea. The company is known for developing advanced therapeutic devices that aim to improve patient outcomes and enhance quality of life. Respicardia's research focuses on neuromodulation and its applications in respiratory health, positioning the organization at the forefront of medical device innovation in the sleep medicine field.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

18 Patents

#33 in Minnetonka, MN

#537 in Minnesota

#17,963 in US

#34,217 in the World

Minnetonka, MN (US)
Minnetonka, MN, United States of America

Respicardia, Inc.

Forward Citations = 620

9 inventors:

goldMedal Mark Gelfand (12 out of 216 patents)

silverMedal Randy W Westlund (11 out of 100 patents)

bronzeMedal Mark C Lynn (6 out of 15 patents)

4.  Howard R Levin (6 out of 131 patents)

5.  Antonis Panteleon (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Respicardia, Inc.. Retrieved from https://idiyas.com/company/respicardia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…